Dalbavancin for treating prosthetic joint infections caused by Gram-positive bacteria: A proposal for a low dose strategy. A retrospective cohort study

BACKGROUND: Gram-positive bacteria are the leading cause of prosthetic joint infection (PJI). Dalbavancin is a lipoglycopeptide with remarkable pharmacokinetic properties and high bactericidal activity against most Gram-positive bacteria. Although clear evidence regarding its effectiveness in bone a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rev Esp Quimioter
Main Authors: Martín, Luis Buzón, Fernández, María Mora, Perales Ruiz, Jose Manuel, Lafont, Maria Ortega, Paredes, Ledicia Álvarez, Morán Rodríguez, Miguel Ángel, Regueras, María Fernández, Machín Morón, Maria Ángeles, Lobón, Gregoria Mejías
Formato: Artigo
Idioma:Inglês
Publicado em: Sociedad Española de Quimioterapia 2019
Assuntos:
Original
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913079/
https://ncbi.nlm.nih.gov/pubmed/31642637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados